Clinical Genitourinary Cancer · 2017 · 11 citations · 14 references
MedicineOncologyPharmacotherapyGenitourinary OncologyMetastasisUrologic OncologyGenitourinary Cancer PharmacotherapyMetastatic Cancer ManagementMetastatic Disease ManagementMetastatic Disease TreatmentMetastatic Urologic CancerProstate CancerAcute Myeloid Leukemia ProgressionAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentCastration-resistant Prostate Cancer TherapyMetastatic Castration-resistant Prostate CancerMetastatic Prostatic CarcinomaOlaparib Therapy
14
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers
Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text
Medicine, Oncology, Pharmacology +17
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso, Yi-Mi Wu, Dan R. Robinson et al. · Nature · 2012 · 2.6K citations
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt et al. · New England Journal of Medicine · 2016 · 2.5K citations · Full text
Medicine, Oncology, Pharmacotherapy +15
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Joaquı́n Mateo, Suzanne Carreira, Shahneen Sandhu et al. · New England Journal of Medicine · 2015 · 2.2K citations · Full text
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai, Shar-yin N. Huang, Benu Brata Das et al. · Cancer Research · 2012 · 2.2K citations · Full text
Medicine, Oncology, Pharmacology +17